Wojewodzki Szpital Specjalistyczny Im. Stefana Kardynala Wyszynskiego Samodzielny Publiczny Zaklad Opieki Zdrowotnej W Lublinie
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At Wojewodzki Szpital Specjalistyczny Im. Stefana Kardynala Wyszynskiego Samodzielny Publiczny Zaklad Opieki Zdrowotnej W Lublinie, research in cardiovascular diseases focuses on serious forms of heart failure and pulmonary hypertension. These studies are designed to evaluate new treatment options, improve symptom control, and better understand long-term safety in people with complex heart and lung circulation problems.
- Combined postcapillary and precapillary pulmonary hypertension related to HFpEF
- Acute and decompensated heart failure across different ejection-fraction groups
- Pulmonary arterial hypertension and related outcomes
The site is contributing to trials that assess whether newer therapies can improve exercise capacity, reduce disease burden, and support safer long-term management for patients with advanced cardiopulmonary disease.
Respiratory Tract Diseases
Clinical research in respiratory tract diseases at this hospital includes studies for people with pulmonary hypertension linked to interstitial lung disease. The main goal is to test whether emerging inhaled or targeted treatments can improve breathing-related function and walking ability in patients affected by these difficult-to-treat conditions.
- Pulmonary hypertension associated with interstitial lung disease
- WHO Group 3 pulmonary hypertension
- Exercise capacity and daily functioning in lung-related vascular disease
These studies reflect a strong interest in improving both symptoms and quality of life for people living with lung disease complicated by elevated pressure in the pulmonary circulation.
Pathological Conditions, Signs and Symptoms
The research portfolio also includes trials addressing broader pathological conditions and treatment outcomes, especially where immune, kidney, and cardiovascular disorders overlap. At this Lublin site, investigators are studying whether established and newer therapies can better control relapse, improve clinical endpoints, and maintain safety over time.
- Idiopathic steroid-sensitive nephrotic syndrome and relapse prevention
- Long-term safety and tolerability of study treatments
- Comparative effectiveness of different therapeutic approaches
This work supports a more personalized approach to care by evaluating how different treatments perform in real patients with complex, recurring, or chronic health problems.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 4 therapeutic areas and 15 of 20 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
- 1Insmed Inc.2active
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Insmed Inc.2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Wojewodzki Szpital Specjalistyczny Im. Stefana Kardynala Wyszynskiego Samodzielny Publiczny Zaklad Opieki Zdrowotnej W Lublinie
lock Showing 1 of 11 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallelgroup Study to Evaluate the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease | Insmed Inc. | Phase III | Recruiting | Feb 2026 | — |
IMP list
lock Showing 1 of 20 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Anastrozole | 2 | Unknown | 2023-07-25 | 2024-03-25 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.